SmartLabs Brings More Biotech to Cambridgeside
SmartLabs will open its fifth and largest Greater Boston location at the Cambridgeside property as developers reposition the mall property for life science tenants.
BXP: Pru Observatory Expected to Become Event Draw
The pending reopening of a new observatory at the Prudential Tower is attracting widespread interest as Boston’s newest location for private events with commanding views, Boston Properties executives said.
Alewife Labs Get 155K SF Lease Expansion
A global biopharma company will occupy an additional 155,000 square feet at 200 Cambridge Park Drive in Alewife after signing a lease expansion.
Funding Climate Clouds Biotech Growth Trajectory
The Boston metro has been a leader in life science research for decades, and while its upward trajectory continued so far this year, a few headwinds are mounting.
Avoid Nightmare Scenarios in a Lab Buildout
Lab planning and programming is often carried out during the architectural design process – after the lease has been signed – exposing tenants to risk that the space cannot support their needs.
Matching Tenants and Landlords in a Shifting Market
Life science brokers like Molly Heath are adjusting to new market fundamentals as they help match biotechs with space availabilities even as the industry’s rapid growth in the last two years cools.
BXP Picks Up Kendall Mid-Rise for $602M
One of Kendall Square’s dominant players just added a new property to its portfolio as troubled life-science firm Biogen exits a major lease nearby.
T’s Troubles Not Putting Off Biotech Tenants
The month-long closure of the MBTA’s Orange Line is not putting off potential biotech tenants in transit-dependent locations despite the “headaches” it’s causing.
Lab Rents Dip in Seaport, Cambridge
Asking rents for lab space in two of the highest-priced local submarkets – Cambridge and Boston’s Seaport District – dipped in the second quarter amid an uptick in subleasing activity.
Biotech Adds 66K SF at Watertown HQ
The initial tenant of a speculative Watertown lab development is more than doubling its space after recently reporting progress on its drug development pipeline.
New Arsenal Lab Building Gets Anchor Lease
A biotech tenant at the Arsenal on the Charles complex in Watertown has committed to expand into a new office-lab building scheduled for completion in mid-2024.
IDB Lab Conversion Attracts Nine Leases
Lab space conversions within Boston’s Innovation and Design Building received strong response from tenants that translated into 260,000 square feet in recent leases.
Eli Lilly Picks Seaport Development for $700M Research Institute
A high-profile development site on Boston’s Fort Point Channel will become the home of a new $700 million Eli Lilly and Co. life science research institute.
Arsenal Yards Gets Another Life Science Lease
Another Cambridge life science company is adding research space in East Watertown’s Arsenal Street industry cluster.
Hot Property: 225 Wyman
Leases totaling over 297,000 square feet bring Hobbs Brook Real Estate’s speculative office-lab complex in Waltham up to 90 percent preleased.
Biotech Leases Spec CambridgeSide Lab Space
A year-old Cambridge biotech company that’s received $315 million in venture financing has leased nearly 150,000 square feet in the Cambridgeside mall’s new office-lab redevelopment.
Hot Property: 34 Commerce Way
A 60,000-square-foot FDA-certified cGMP drug manufacturing facility formerly occupied by Amgen is available for lease in early 2022.
Bluebird Bio to Downsize in Move to Assembly Row
Cambridge-based Bluebird Bio is leaving pricey Kendall Square for Somerville’s Assembly Row in a real estate deal that’s expected to save the company $120 million over the next six years.
Hot Property: 22 Thomson Place
Halloran Consulting Group has leased 25,500 square feet at 22 Thomson Place in Boston’s Fort Point for a relocated and expanded headquarters.
Moderna Leases New HQ at Alexandria Development in Kendall Square
Moderna Pharmaceuticals has leased 462,000 square feet at Alexandria Real Estate Equities’ 325 Binney St. in Cambridge for a new headquarters and R&D facility.
